National trends, complications, and hospital charges in pediatric patients with chiari malformation type i treated with posterior fossa decompression with and without duraplasty

Faris Shweikeh, Dharma Sunjaya, Miriam A Nuno, Doniel Drazin, Mathew A. Adamo

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: The treatment of type 1 Chiari malformation (CM-1) with posterior fossa decompression without (PFD) or with duraplasty (PFDD) is controversial. The authors analyze both options in a national sample of pediatric patients. Methods: Utilizing the Kids' Inpatient Database, CM-1 patients undergoing PFD or PFDD from 2000 through 2009 were analyzed. Results: 1,593 patients with PFD and 1,056 with PFDD were evaluated. The average age was 10.3 years, slightly younger in PFD (9.8 vs. 10.9 years, p = 0.001). PFDD patients were more likely White (81.2 vs 75.6%, p = 0.04) and less likely admitted emergently (8.4 vs. 13.8%, p = 0.007). They also underwent more reoperations (2.1 vs. 0.7%, p = 0.01), had more procedure-related complications (2.3 vs. 0.8%, p = 0.003), a longer length of stay (4.4 vs. 3.8 days, p = 0.001) and higher charges (USD 35,321 vs. 31,483, p = 0.01). Conclusions: This large national study indicates that PFDD is performed more often in Caucasians, less so emergently, and associated with significantly more complications and immediate reoperations, while PFD is more frequent in those with syringomyelia and more economical, requiring fewer hospital resources. Overall, PFD is more favorable for CM-1, though it would be prudent to conduct a prospective trial, as this analysis is limited by data on preoperative presentations and long-term outcomes.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalPediatric Neurosurgery
Volume50
Issue number1
DOIs
StatePublished - Apr 6 2015
Externally publishedYes

Fingerprint

Hospital Charges
Decompression
Pediatrics
Reoperation
Arnold-Chiari Malformation
Syringomyelia
Inpatients
Length of Stay
Databases

Keywords

  • Adolescents
  • Chiari malformation
  • Children
  • Complications
  • Posterior fossa decompression
  • Surgical treatment
  • Syringomyelia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery
  • Clinical Neurology

Cite this

National trends, complications, and hospital charges in pediatric patients with chiari malformation type i treated with posterior fossa decompression with and without duraplasty. / Shweikeh, Faris; Sunjaya, Dharma; Nuno, Miriam A; Drazin, Doniel; Adamo, Mathew A.

In: Pediatric Neurosurgery, Vol. 50, No. 1, 06.04.2015, p. 31-37.

Research output: Contribution to journalArticle

@article{b46118b22f664b4bad3eda5366ab63f8,
title = "National trends, complications, and hospital charges in pediatric patients with chiari malformation type i treated with posterior fossa decompression with and without duraplasty",
abstract = "Background: The treatment of type 1 Chiari malformation (CM-1) with posterior fossa decompression without (PFD) or with duraplasty (PFDD) is controversial. The authors analyze both options in a national sample of pediatric patients. Methods: Utilizing the Kids' Inpatient Database, CM-1 patients undergoing PFD or PFDD from 2000 through 2009 were analyzed. Results: 1,593 patients with PFD and 1,056 with PFDD were evaluated. The average age was 10.3 years, slightly younger in PFD (9.8 vs. 10.9 years, p = 0.001). PFDD patients were more likely White (81.2 vs 75.6{\%}, p = 0.04) and less likely admitted emergently (8.4 vs. 13.8{\%}, p = 0.007). They also underwent more reoperations (2.1 vs. 0.7{\%}, p = 0.01), had more procedure-related complications (2.3 vs. 0.8{\%}, p = 0.003), a longer length of stay (4.4 vs. 3.8 days, p = 0.001) and higher charges (USD 35,321 vs. 31,483, p = 0.01). Conclusions: This large national study indicates that PFDD is performed more often in Caucasians, less so emergently, and associated with significantly more complications and immediate reoperations, while PFD is more frequent in those with syringomyelia and more economical, requiring fewer hospital resources. Overall, PFD is more favorable for CM-1, though it would be prudent to conduct a prospective trial, as this analysis is limited by data on preoperative presentations and long-term outcomes.",
keywords = "Adolescents, Chiari malformation, Children, Complications, Posterior fossa decompression, Surgical treatment, Syringomyelia",
author = "Faris Shweikeh and Dharma Sunjaya and Nuno, {Miriam A} and Doniel Drazin and Adamo, {Mathew A.}",
year = "2015",
month = "4",
day = "6",
doi = "10.1159/000371659",
language = "English (US)",
volume = "50",
pages = "31--37",
journal = "Pediatric Neurosurgery",
issn = "1016-2291",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - National trends, complications, and hospital charges in pediatric patients with chiari malformation type i treated with posterior fossa decompression with and without duraplasty

AU - Shweikeh, Faris

AU - Sunjaya, Dharma

AU - Nuno, Miriam A

AU - Drazin, Doniel

AU - Adamo, Mathew A.

PY - 2015/4/6

Y1 - 2015/4/6

N2 - Background: The treatment of type 1 Chiari malformation (CM-1) with posterior fossa decompression without (PFD) or with duraplasty (PFDD) is controversial. The authors analyze both options in a national sample of pediatric patients. Methods: Utilizing the Kids' Inpatient Database, CM-1 patients undergoing PFD or PFDD from 2000 through 2009 were analyzed. Results: 1,593 patients with PFD and 1,056 with PFDD were evaluated. The average age was 10.3 years, slightly younger in PFD (9.8 vs. 10.9 years, p = 0.001). PFDD patients were more likely White (81.2 vs 75.6%, p = 0.04) and less likely admitted emergently (8.4 vs. 13.8%, p = 0.007). They also underwent more reoperations (2.1 vs. 0.7%, p = 0.01), had more procedure-related complications (2.3 vs. 0.8%, p = 0.003), a longer length of stay (4.4 vs. 3.8 days, p = 0.001) and higher charges (USD 35,321 vs. 31,483, p = 0.01). Conclusions: This large national study indicates that PFDD is performed more often in Caucasians, less so emergently, and associated with significantly more complications and immediate reoperations, while PFD is more frequent in those with syringomyelia and more economical, requiring fewer hospital resources. Overall, PFD is more favorable for CM-1, though it would be prudent to conduct a prospective trial, as this analysis is limited by data on preoperative presentations and long-term outcomes.

AB - Background: The treatment of type 1 Chiari malformation (CM-1) with posterior fossa decompression without (PFD) or with duraplasty (PFDD) is controversial. The authors analyze both options in a national sample of pediatric patients. Methods: Utilizing the Kids' Inpatient Database, CM-1 patients undergoing PFD or PFDD from 2000 through 2009 were analyzed. Results: 1,593 patients with PFD and 1,056 with PFDD were evaluated. The average age was 10.3 years, slightly younger in PFD (9.8 vs. 10.9 years, p = 0.001). PFDD patients were more likely White (81.2 vs 75.6%, p = 0.04) and less likely admitted emergently (8.4 vs. 13.8%, p = 0.007). They also underwent more reoperations (2.1 vs. 0.7%, p = 0.01), had more procedure-related complications (2.3 vs. 0.8%, p = 0.003), a longer length of stay (4.4 vs. 3.8 days, p = 0.001) and higher charges (USD 35,321 vs. 31,483, p = 0.01). Conclusions: This large national study indicates that PFDD is performed more often in Caucasians, less so emergently, and associated with significantly more complications and immediate reoperations, while PFD is more frequent in those with syringomyelia and more economical, requiring fewer hospital resources. Overall, PFD is more favorable for CM-1, though it would be prudent to conduct a prospective trial, as this analysis is limited by data on preoperative presentations and long-term outcomes.

KW - Adolescents

KW - Chiari malformation

KW - Children

KW - Complications

KW - Posterior fossa decompression

KW - Surgical treatment

KW - Syringomyelia

UR - http://www.scopus.com/inward/record.url?scp=84926408285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926408285&partnerID=8YFLogxK

U2 - 10.1159/000371659

DO - 10.1159/000371659

M3 - Article

C2 - 25721939

AN - SCOPUS:84926408285

VL - 50

SP - 31

EP - 37

JO - Pediatric Neurosurgery

JF - Pediatric Neurosurgery

SN - 1016-2291

IS - 1

ER -